The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients-Reference-Cited by-同舟云学术

The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients

Published:2020-06-30 Issue:1 Volume:9 Page:
ISSN:2047-2994
Container-title:Antimicrobial Resistance & Infection Control
language:en
Short-container-title:Antimicrob Resist Infect Control

Author:

Krutova Marcela,Capek Vaclav,Nycova Elka,Vojackova Sabina,Balejova Magda,Geigerova Lenka,Tejkalova Renata,Havlinova Lenka,Vagnerova Iva,Cermak Pavel,Ryskova Lenka,Jezek Petr,Zamazalova Dana,Vesela Denisa,Kucharova Alice,Nemcova Dana,Curdova Martina,Nyc Otakar,Drevinek Pavel

Funder

Ministerstvo Zdravotnictví Ceské Republiky

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s13756-020-00765-y.pdf

Reference30 articles.

1. Oren A, Rupnik M. Clostridium difficile and Clostridioides difficile: two validly published and correct names. Anaerobe. 2018;52:125–6. https://doi.org/10.1016/j.anaerobe.2018.07.005 .

2. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013.

3. Krutova M, Kinross P, Barbut F, Hajdu A, Wilcox MH, Kuijper EJ, Survey contributors. How to: surveillance of Clostridium difficile infections. Clin Microbiol Infect. 2018;24(5):469–75. https://doi.org/10.1016/j.cmi.2017.12.008 .

4. Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl 2):1–26. https://doi.org/10.1111/1469-0691.12418 .

5. Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017;17(4):411–21. https://doi.org/10.1016/S1473-3099(16)30514-X .

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of 30-day antecedent antibiotic exposure on Clostridioides difficile ribotype patterns and the relationship with clinical outcomes: A single center study;Anaerobe;2024-10

2. Host-defense piscidin peptides as antibiotic adjuvants against Clostridioides difficile;PLOS ONE;2024-01-22

3. Antibiotic Resistances of Clostridioides difficile;Advances in Experimental Medicine and Biology;2024

4. Characteristics of Clostridioides difficile isolates circulating in the Slovak hospitals;Biologia;2023-07-31

5. Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018–2019;International Journal of Antimicrobial Agents;2023-07